Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database
Arquivos de Neuro-Psiquiatria · 01.12.2025 · 83 (12) · 001-008
DOI: 10.1055/s-0045-1813263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arquivos de Neuro-Psiquiatria, erschienen am 01.12.2025. Verfasst von Alfredo Damasceno und 24 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil. Hauptthemen laut MEDLINE: Health Services Accessibility, Multiple Sclerosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disorder whose prevalence varies across Brazil (from 15–27 cases per 100 thousand inhabitants), and the absence of an extensive national study limits the understanding of MS epidemiology in a nation as diverse as Brazil. To compare epidemiological data, including healthcare access, among people with MS across four Brazilian regions. Data from 2,974 Brazilian MS patients in the Collaborative Latin American Database for Multiple Sclerosis (BRANDO) were analyzed. We assessed demographic and clinical outcomes, as well as healthcare access, to elucidate regional differences. The cohort was predominantly composed of female patients (72.5%) with MS onset at a mean age of 30.6 years. Regarding the regional differences, there was a lower predominance of female patients (68.7%; p = 0.003) in the Southeast, a higher rate of subjects of mixed ethnicity (p < 0.001) in the Midwest (40.3%) and Northeast (63.7%), higher scores on the Expanded Disability Status Scale (EDSS) in the Northeast (4.0; p < 0.001), a higher prevalence of relapsing-remitting MS (RRMS) in the Southeast and Midwest (87%; p < 0.001), while the Northeast presented (p < 0.001) the highest rates of primary progressive MS (PPMS) and secondary progressive MS (SPMS) (PPMS = 15.8%; SPMS = 18%). The Northeast presented the longest time (5.9 years; p < 0.01) from disease onset until MS diagnosis (range for the other regions = 1.9–3.7 years). And the Midwest showed the shortest time (2.1 years; p < 0.01) from disease onset until first access to disease-modifying therapies (DMTs; range for the other regions = 3.5–5.1 years). The present is the first nationwide epidemiological study on people with MS in Brazil. It underscores regional epidemiological variations and differences in healthcare access, advocating for tailored approaches in MS management and research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil.
- University of Hasselt, Rehabilitation Research Center (REVAL), Faculty of Rehabilitation Sciences, Hasselt, Belgium.
- Universidade de Brasília, Brasília DF, Brazil.
- Instituto Neurológico de Curitiba, Departamento de Neuroimunologia, Curitiba PR, Brazil.
- Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.
- Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo SP, Brazil.
ORCID-Profile: Alfredo Damasceno, Cintia Ramari, Carlos Tauil, Henry Koiti Sato, Dagoberto Callegaro, Maria Fernanda Mendes, José Artur Costa D'Almeida, Denise Sisterolli Diniz, Osvaldo J M Nascimento, Laura Parolin, Thiago Fukuda, Paulo Gama, Herval Soares Neto, Marco Lana-Peixoto, Giordani Rodrigues Dos Passos, Rayllene Caetano, Kleber Cavalcante Santos, Caio César Diniz Disserol, Gabriel de Deus Vieira, Guilherme Diogo Silva, Eliana Cunha, Natália Talim, Mario B Wagner, Milena Sales Pitombeira, Jefferson Becker
Zitieren
APA
Damasceno, A., Ramari, C., Tauil, C., Sato, H. K., Callegaro, D., Mendes, M. F., D'Almeida, J. A. C., Diniz, D. S., Nascimento, O. J. M., Parolin, L., Fukuda, T., Gama, P., Neto, H. S., Lana-Peixoto, M., Passos, G. R. D., Caetano, R., Santos, K. C., Disserol, C. C. D., Vieira, G. D., …, & Becker, J. (2025). Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database. Arquivos de Neuro-Psiquiatria, 83(12), 001-008. https://doi.org/10.1055/s-0045-1813263
Vancouver
Damasceno A, Ramari C, Tauil C, Sato HK, Callegaro D, Mendes MF, et al. Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database. Arquivos de Neuro-Psiquiatria. 2025;83(12):001-008. doi:10.1055/s-0045-1813263
BibTeX
@article{Damasceno2025,
author = {Damasceno, Alfredo and Ramari, Cintia and Tauil, Carlos and Sato, Henry Koiti and Callegaro, Dagoberto and Mendes, Maria Fernanda and D'Almeida, José Artur Costa and Diniz, Denise Sisterolli and Nascimento, Osvaldo J M and Parolin, Laura and Fukuda, Thiago and Gama, Paulo and Neto, Herval Soares and Lana-Peixoto, Marco and Passos, Giordani Rodrigues Dos and Caetano, Rayllene and Santos, Kleber Cavalcante and Disserol, Caio César Diniz and Vieira, Gabriel de Deus and Silva, Guilherme Diogo and Cunha, Eliana and Talim, Natália and Wagner, Mario B and Pitombeira, Milena Sales and Becker, Jefferson},
title = {Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database},
journal = {Arquivos de Neuro-Psiquiatria},
year = {2025},
volume = {83},
number = {12},
pages = {001--008},
doi = {10.1055/s-0045-1813263}
}
EUVIMED